Aβ-oligomer uptake and the resulting inflammatory response in adult human astrocytes are precluded by an anti-Aβ single chain variable fragment in combination with an apoE mimetic peptide

This publication has 57 references indexed in Scilit:

• ApoE influences amyloid-β (Aβ) clearance despite minimal apoE/Aβ association in physiological conditions
  Proceedings of the National Academy of Sciences, 2013
• Clearance of Amyloid-β Peptides By Microglia and Macrophages: the Issue of What, When and Where
  Future Neurology, 2012
• APOE-Mimetic Peptides Reduce Behavioral Deficits, Plaques and Tangles in Alzheimer’s Disease Transgenics
  Neurodegenerative Diseases, 2012
• Decreased Clearance of CNS β-Amyloid in Alzheimer’s Disease
  Science, 2010
• Anti-inflammatory and recycling properties of an apolipoprotein mimetic peptide, Ac-hE18A-NH2
  Atherosclerosis, 2010
• Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease
  Nature Genetics, 2009
• Monocyte Chemoattractant Protein‐1 Plays a Dominant Role in the Chronic Inflammation Observed in Alzheimer's Disease
  Brain Pathology, 2009
• Apolipoprotein E and its receptors in Alzheimer's disease: pathways, pathogenesis and therapy
  Nature Reviews Neuroscience, 2009
• Transport Pathways for Clearance of Human Alzheimer's Amyloid β-Peptide and Apolipoproteins E and J in the Mouse Central Nervous System
  Journal of Cerebral Blood Flow & Metabolism, 2007
• Amelioration of amyloid load by anti-Aβ single-chain antibody in Alzheimer mouse model
  Biochemical and Biophysical Research Communications, 2006